Leerink Partners initiated coverage on Arcturus Therapeutics with a new price target

8/12/24 7:16:41 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Leerink Partners initiated coverage of Arcturus Therapeutics with a rating of Outperform and set a new price target of $70.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ARCT

Date	Price Target	Rating	Analyst
5/28/2025	$32.00	Sector Outperform	Scotiabank
1/28/2025	$41.00	Buy	BTIG Research
8/12/2024	$70.00	Outperform	Leerink Partners
12/13/2023	$90.00	Buy	Canaccord Genuity
7/24/2023	$71.00	Outperform	William Blair
5/11/2023	$19.00 → $51.00	Neutral → Buy	H.C. Wainwright
11/14/2022	$35.00	Overweight	Wells Fargo
11/10/2022	$18.00	Neutral → Underperform	Robert W. Baird